Bristol Myers Squibb (BMY) Doubles Down on Nvidia (NVDA) AI Tech for Drug Development

Bristol Myers Squibb (BMY) expands Nvidia (NVDA) partnership with second DGX SuperPOD, delivering 10x performance boost for AI-driven drug discovery.

The post Bristol Myers Squibb (BMY) Doubles Down on Nvidia (NVDA) AI Tech for Drug Development appeared first on Blockonomi.